+52.1%
CME vs VRSK
-26.5%
+78.5%
-31.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VRSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | +0.2% | +0.3% | +0.5% |
| 7D | -1.6% | -5.2% | +3.6% | -0.7% |
| 30D | +5.6% | -2.3% | +7.9% | +6.0% |
| 3M | +5.6% | -2.9% | +8.5% | +5.9% |
| 6M | -8.3% | -12.8% | +4.5% | -6.3% |
| YTD | +4.3% | -20.8% | +25.2% | +8.7% |
| 1Y | +9.1% | -33.2% | +42.3% | +18.1% |
| 3Y | +52.1% | -26.6% | +78.6% | +65.0% |
| All | +52.1% | -26.5% | +78.5% | +65.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSK.
Daily Out/Under-Performance
Portfolio return minus VRSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VRSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling